Bengaluru, January 16, 2025: In the ongoing battle against breast cancer, advancements in technology are transforming treatment approaches, improving patient outcomes, and enhancing quality of life. Apollo Cancer Centre (ACC), Bengaluru, has successfully conducted India’s first Robotic Nipple-Sparing Mastectomy (RNSM) combined with TiLoop implant reconstruction, a groundbreaking development in breast surgery.
This innovative procedure was performed on two patients: Latha, a 37-year-old diagnosed with right breast cancer in April 2024, and Sneha T (name changed), a 48-year-old diagnosed in October 2024. Both underwent RNSM with TiLoop and subsequent implant reconstruction, demonstrating the successful application of this advanced technique in India.
RNSM is a minimally invasive procedure that removes breast tissue while preserving the nipple-areola complex (NAC) and natural breast contours. Performed using the da Vinci Surgical System, it offers enhanced precision, reduced scarring, and faster recovery compared to traditional mastectomy.
The TiLoop Bra, a titanium-coated polypropylene mesh, plays a crucial role in the reconstruction process. It provides structural support to the implant, preventing displacement and promoting tissue integration. This minimizes the risk of complications like capsular contracture and enhances the aesthetic outcome.
Prior to these landmark surgeries, breast reconstruction in India primarily relied on autologous tissue techniques, such as the Latissimus Dorsi (LD) flap. This method involves harvesting tissue from the patient’s back, leading to increased surgical time, higher risks of complications, and prolonged recovery.
“Robotic nipple-sparing mastectomy with TiLoop implant reconstruction represents the perfect blend of precision technology and innovative reconstructive techniques,” says Dr. Jayanti Thumsi, Lead Surgeon and Robotic Breast Surgeon at Apollo Cancer Centre, Bangalore. “This approach offers a safer and less invasive alternative, encouraging more Indian women to consider reconstruction post-mastectomy. It not only ensures effective cancer clearance but also prioritizes the patient’s emotional well-being and quality of life.”
Mr. Dinesh Madhavan, President Group Oncology and International, Apollo Hospitals Enterprise Ltd (AHEL), emphasized the significance of this advancement: “Robotics has revolutionized cancer care, and the integration of advanced materials like the TiLoop mesh enhances surgical accuracy and patient outcomes. This approach demonstrates Apollo’s commitment to providing the most advanced and effective cancer care to our patients.”
Dr. Manish Mattoo, CEO – Karnataka & Central Region, AHEL, highlighted the potential impact of this technique: “The introduction of TiLoop mesh is likely to address concerns that have traditionally deterred Indian women from opting for reconstruction. Its minimally invasive nature, combined with better outcomes and shorter recovery times, makes it an attractive option for patients hesitant about traditional procedures.”
These successful surgeries at Apollo Cancer Centre mark a significant milestone in breast cancer treatment in India. By offering patients access to cutting-edge technologies like RNSM with TiLoop reconstruction, Apollo continues to drive innovation in cancer care and improve the lives of those affected by this disease.
